Patent · US Active

Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome

US8642548B2 · kind B2 · utility

38Cited by

5References

19Claims

0Family size

Assignee

MannKind Corporation · US

Inventors

Peter Richardson · Beaverton, US
Enda Kenny · Dublin, IE
Per Hellstrom · Bromma, SE
Marshall L. Grant · Newtown, US
Grayson W. Stowell · Gaylordsville, US
Scott Daniels · Cheshire, US
Anthony Smithson · Santa Clarita, US
Stephanie Greene · Ventura, US

Key dates

Filing date	Aug 5, 2010
Grant date	Feb 4, 2014
Priority date	—
Expiry date	Aug 5, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating functional dyspepsia and/or irritable bowel syndrome in mammals in need of treatment is disclosed herein. The method comprises administering to the mammal a formulation by inhalation, wherein the formulation avoids first pass metabolism of the active ingredient. The method comprises administering a formulation by pulmonary inhalation comprising a diketopiperazine and a glucagon-like peptide (GLP-1), analog, ROSE-010.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.